Auron Therapeutics, Inc. research brief

CIK 1746139 Copy CIK

Generated Nov. 13, 2026, 6:51 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: Wellesley Massachusetts. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Aug. 13, 2026 · D · 0001746139-26-000002 · Source evidence

  Reported offering amount: 12000000 USD. Reported amount sold: 7118141 USD.

• Dec. 23, 2025 · D/A · 0001746139-25-000003 · Source evidence

  Reported offering amount: 42289180 USD. Reported amount sold: 27289180 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Auron Therapeutics, Inc. research brief,” CIK 1746139, retrieved Nov. 13, 2026, 6:51 p.m.. Cite the specific accessions used. No amounts have been summed.